Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer

BACKGROUND: Programmed cell death 4 (Pdcd4) is a novel tumour suppressor and originally identified as a neoplastic transformation inhibitor. The aim of this study was to investigate the expression, prognostic significance and potential function of Pdcd4 in ovarian cancer. RESULTS: The expression of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Na, Liu, Stephanie S, Leung, Thomas HY, Tam, Kar F, Liao, Xiao Y, Cheung, Annie NY, Chan, Karen KL, Ngan, Hextan YS
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745358/
https://www.ncbi.nlm.nih.gov/pubmed/19728867
http://dx.doi.org/10.1186/1476-4598-8-70

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745358/
https://www.ncbi.nlm.nih.gov/pubmed/19728867
http://dx.doi.org/10.1186/1476-4598-8-70

Ejemplares similares